BC
VERA icon

Birchview Capital’s Vera Therapeutics VERA Stock Holding History

Birchview Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
57,758
+13,758
+31% +$513K 1.16% 22
2026
Q1 		$1.77M Hold
44,000
– – 1.01% 29
2025
Q4 		$2.23M Buy
+44,000
New +$1.56M 1.3% 21

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Birchview Capital's VERA Position: Q2 2026 in Review

Birchview Capital increased its Vera Therapeutics (VERA) stake by 31% in Q2 2026, buying an estimated $513K and bringing the position to 57,758 shares worth $2.48M. The position accounts for 1.16% of the portfolio, ranked #22.

Birchview Capital first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Birchview Capital held 57,758 shares of Vera Therapeutics worth $2.48M as of Q2 2026.
  • Birchview Capital bought 13,758 Vera Therapeutics shares in Q2 2026, an estimated $513K.
  • Vera Therapeutics made up 1.16% of Birchview Capital's portfolio in Q2 2026, its #22 holding.
  • Birchview Capital first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.